Newton, MA, United States of America

Peter Germano

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Peter Germano

Introduction

Peter Germano is an accomplished inventor based in Newton, MA, with a notable portfolio of four patents. His work primarily focuses on advancements in pharmaceutical formulations and treatments for various diseases, particularly those related to the central nervous system.

Latest Patents

Germano's latest patents include innovative sGC stimulators. These stimulators are designed to enhance the activity of soluble guanylate cyclase (sGC), which plays a crucial role in various physiological processes. The formulations aim to treat diseases where an increase in nitric oxide (NO) and cyclic Guanosine Monophosphate (cGMP) is beneficial. Another significant patent addresses the treatment of central nervous system (CNS) diseases using sGC stimulators, emphasizing the importance of upregulating the NO pathway for effective therapy.

Career Highlights

Throughout his career, Germano has contributed to the field of pharmaceuticals by working with prominent companies such as Cyclerion Therapeutics, Inc. and Tisento Therapeutics Inc. His expertise in developing innovative treatments has made a significant impact on the industry.

Collaborations

Germano has collaborated with notable professionals in his field, including Rajesh R Iyengar and Thomas Wai-Ho Lee. These partnerships have further enhanced his research and development efforts.

Conclusion

Peter Germano's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for innovative treatments that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…